Certolizumab pegol Completed Phase 3 Trials for Moderate and Severe Active Rheumatoid Arthritis / active Ankylosing spondylitis / Psoriatic arthritis aggravated / Moderately to Severely Active Crohn's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03357471Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease